n-ethyl-3-piperidyl benzilate has been researched along with Peptic Ulcer in 1 studies
*Peptic Ulcer: Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BAUZON, M; DORNIER, R; FONDER, A; HEULLY, F; MESSENET, M | 1 |
1 other study(ies) available for n-ethyl-3-piperidyl benzilate and Peptic Ulcer
| Article | Year |
|---|---|
[1st clinical trials of a new parasym-patholytic: the bromomethylate of N-ethyl-3-piperidyl benzilate (or compound AN 1111 or Piptal) in the treatment of peptic ulcer].
Topics: Benzilates; Parasympatholytics; Peptic Ulcer; Piperidines | 1961 |